Heather Berger, Ph.D., is a Venture Partner at Forge Life Science Partners, a boutique life science investment fund, focused on novel therapeutics including respiratory products. She is currently a Board Observer for Kinaset Therapeutics, focused on novel inhaled therapeutics for asthma. Prior to this, she served in a variety of operational roles including Chief Business Officer of Iolyx Therapeutics. Heather was previously principal at SR One and at Sofinnova Investments, concentrating on novel opportunities across therapeutic areas; she is a Board Member of Design Therapeutics. Previously, she was an equity research analyst, a chemist at the Astellas Research Institute, and adjunct faculty at the Feinberg Northwestern School of Medicine. Heather received her Ph.D. in chemistry at Northwestern University, MSc. in organic chemistry at the Weizmann Institute of Science and her B.S. from Tufts University.